Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Pebble Gro. Regulatory News (PEBB)

Share Price Information for The Pebble Gro. (PEBB)

Share Price is delayed by 15 minutes
Get Live Data
61.00    0.00 (0.00%)
Bid:
60.00
Ask:
62.00
Spread: 2.00 (3.333%)
Market Cap: £88.88m
PEBB Live PriceLast checked at - London Stock Exchange

Intraday The Pebble Gro. Share Chart

Directorate Change

30 Apr 2024 07:00

RNS Number : 4973M
Pebble Group PLC (The)
30 April 2024
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

30 April 2024

THE PEBBLE GROUP PLC

("The Pebble Group" or the "Group")

 

Directorate Change

 

The Pebble Group (AIM: PEBB, OTCQX: PEBBF), a leading provider of digital commerce, products and related services to the global promotional products industry, announces changes to its Board of Directors.

 

As a consequence of his growing private sector business commitments, Richard Law has resigned as Chair and as a Non-Executive Director of the Group. The Board is comfortable in accepting this resignation with immediate effect because it is confident that the number, depth of experience and commitment of the continuing Directors is strong, and because this change is not expected to have any impact on the Group's current trading, teams or customer and supplier relationships. As a result, resolution 4 (to re-elect Richard Law as a Director) as set out in the notice of today's Annual General Meeting has been withdrawn by the Company.

 

Due to their existing external commitments, the Board's three continuing independent Non-Executive Directors have asked the Group CEO, Chris Lee, to take a short-term interim Chair role alongside his current duties until a new independent Non-Executive Chair is appointed, the search for which is underway. The Board recognises the importance of an independent Non-Executive Chair and will seek to ensure that the separation of Chair and CEO roles is resumed as soon as possible. There will be no change to Chris' remuneration or other terms of employment during this short-term period and we will update on the progress of the independent Non-Executive Chair search in future market updates.

 

The Board would like to thank Richard for his input and counsel and for supporting the teams in developing and implementing the Group's strategies and growth plans since its IPO in 2019. The remaining independent Non-Executive Directors would also like to thank Chris for agreeing to step in as interim Chair until a permanent independent Non-Executive Chair is appointed.

 

Richard Law commented: "I would like to thank the Board and teams across our businesses globally for their help and support over my last four years as Chair. I have particularly enjoyed visiting our sites in the USA and UK, to build an understanding of our businesses and see what a great job our people do day-to-day. During that time, our teams of talented people have developed Facilisgroup and Brand Addition into strongly differentiated propositions with significant future potential, through a focus on technology, sustainability and building deep and trusted relationships with customers and other key stakeholders. I wish The Pebble Group and its people every success in continuing to grow."

 

Chris Lee, CEO of The Pebble Group commented: "We thank Richard for his counsel and support during his time with The Pebble Group and wish him well. The Board is looking forward to recruiting a new Chair to support value creation for our shareholders."

 

 

Enquiries:

 

The Pebble Group

Chris Lee, Chief Executive Officer

Claire Thomson, Chief Financial Officer

+44 (0) 750 012 4121

Temple Bar Advisory (Financial PR)

Alex Child-Villiers

Sam Livingstone

+44 (0) 207 183 1190

pebble@templebaradvisory.com

 

 

 

Grant Thornton UK LLP (Nominated Adviser)

Samantha Harrison / Harrison Clarke / Ciara Donnelly

+44 (0) 207 184 4384

Berenberg (Corporate Broker)

Ben Wright / Mark Whitmore / Richard Andrews

+44 (0) 203 207 7800 

 

About The Pebble Group

 

The Pebble Group is a provider of digital commerce, products and related services to the global promotional products industry, comprising two differentiated businesses, Facilisgroup and Brand Addition, focused on specific areas of the promotional products market. For further information, please visit www.thepebblegroup.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADGGDSRSDDGSC
Date   Source Headline
3rd Jun 20267:00 amRNSTransaction in Own Shares
26th May 20265:50 pmRNSBlock Admission Return
14th May 20265:06 pmRNSDirector/PDMR Shareholding
13th May 20264:55 pmRNSHolding(s) in Company
8th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20262:31 pmRNSResult of Annual General Meeting 2026
29th Apr 20267:00 amRNSAGM Trading Update and Notice of Results
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 202612:21 pmRNSPurchase of Shares by Employee Benefit Trust
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20264:02 pmRNSHolding(s) in Company
30th Mar 20262:08 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNS2025 Annual Report, ESG Report and Notice of AGM
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSLaunch of Share Buyback Programme
17th Mar 20267:00 amRNSLaunch of Share Buyback Programme
17th Mar 20267:00 amRNSAUDITED FULL YEAR RESULTS 2025
17th Mar 20267:00 amRNSAUDITED FULL YEAR RESULTS 2025
13th Feb 202612:22 pmRNSHolding(s) in Company
2nd Feb 20265:23 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSTrading Update and Notice of Results
13th Jan 20266:20 pmRNSHolding(s) in Company
12th Jan 20264:23 pmRNSHolding(s) in Company
2nd Dec 20254:28 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20253:41 pmRNSPurchase of Shares by Employee Benefit Trust
26th Nov 20257:00 amRNSBlock Admission Return
24th Nov 20253:11 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20252:22 pmRNSPurchase of Shares by Employee Benefit Trust
13th Oct 20251:22 pmRNSHolding(s) in Company
9th Sep 20257:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.